Telmisartan HCTZ 80 mg / 25 mg – DIN 02390310
Telmisartan HCTZ is Telmisartan and Hydrochlorothiazide 80 mg / 25 mg (tablet), sold in Canada. It is used for high blood pressure. It is supplied by Sivem Pharmaceuticals ULC. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Telmisartan and Hydrochlorothiazide 80 mg / 25 mg
- Brand
- Telmisartan HCTZ
- Strength
- Telmisartan 80 mg / Hydrochlorothiazide 25 mg
- Used for
- High blood pressure
- Form
- Tablet
- Manufacturer
- Sivem Pharmaceuticals ULC
- Drug class
- ARB (blood pressure medicine)
- Sold in
- Canada
- DIN
- 02390310
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Telmisartan and Hydrochlorothiazide used for?
Telmisartan and Hydrochlorothiazide is used for high blood pressure.
- Medicine type
- ARB (blood pressure medicine); thiazide diuretic (water pill)
Official uses from the US prescribing label
Telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the classes to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with telmisartan and hydrochlorothiazide tablets.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Telmisartan and hydrochlorothiazide tablets are not indicated for initial therapy for the treatment of hypertension.
Telmisartan and hydrochlorothiazide tablets may be used alone or in combination with other antihypertensive agents.
From the FDA-approved label on DailyMed (published Sep 10, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02390310.
- It names Telmisartan HCTZ, Telmisartan and Hydrochlorothiazide 80 mg / 25 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Telmisartan HCTZ by Sivem Pharmaceuticals ULC.
In Canada: prescription only.
Ingredients
Active: Telmisartan, Hydrochlorothiazide
Other Telmisartan and Hydrochlorothiazide pills
-
423
Telmisartan and Hydrochlorothiazide 40 mg / 12.5 mg
Orange & white, capsule, 15 mm
Used for high blood pressure
-
424
Telmisartan and Hydrochlorothiazide 80 mg / 12.5 mg
Orange & white, capsule, 17 mm
Used for high blood pressure
- LU M31 Telmisartan and Hydrochlorothiazide 12.5 mg / 40 mg Red & white, oval, 14 mm Used for high blood pressure
- LU M32 Telmisartan and Hydrochlorothiazide 12.5 mg / 80 mg Red & white, capsule, 18 mm Used for high blood pressure
- L200 Hydrochlorothiazide and Telmisartan 12.5 mg / 80 mg Pink & white, capsule Used for high blood pressure
- LU M33 Telmisartan and Hydrochlorothiazide 25 mg / 80 mg White & yellow, capsule, 18 mm Used for high blood pressure
- H4 Telmisartan and Hydrochlorothiazide 40 mg / 12.5 mg Red & white, oval, 14 mm Used for high blood pressure
- L199 Telmisartan and Hydrochlorothiazide 40 mg / 12.5 mg Pink & white, capsule, 14 mm Used for high blood pressure